Actemra 80 mg/4 ml

Actemra 80 mg/4 ml is a medicine authorised by Swissmedic under authorisation number 58868. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 02 December 2008 and the authorisation is valid without a time limit. ATC code L04AC07 places the medicine in the group Immunosuppressants.

  • Dispensing category A
  • Authorisation number 58868
  • ATC L04AC07
  • Biotechnological medicines
Authorisation data
Authorisation number58868
NameActemra 80 mg/4 ml
Full nameActemra 80 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderRoche Pharma (Schweiz) AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL04AC07
First authorisation02 December 2008
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Actemra 80 mg/4 ml, Konzentrat zur Herstellung einer InfusionslösungA02 December 2008
2Actemra 200 mg/10 ml, Konzentrat zur Herstellung einer InfusionslösungA02 December 2008
3Actemra 400 mg/20 ml, Konzentrat zur Herstellung einer InfusionslösungA02 December 2008

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L04AC0707.15.0.A
21Durchstechflasche(n)L04AC0707.15.0.A
31Durchstechflasche(n)L04AC0707.15.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Actemra 80 mg/4 ml authorised in Switzerland?

Yes. Actemra 80 mg/4 ml is authorised by Swissmedic under authorisation number 58868, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Actemra 80 mg/4 ml have?

Actemra 80 mg/4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Actemra 80 mg/4 ml?

The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com